U.S. FDA Approval Of Oral Gilenya Sends Mitsubishi Tanabe Shares Soaring
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Tanabe Pharma shares jumped on the report that U.S. FDA has approved multiple sclerosis drug Gilenya (fingolimod)